top of page

Immunocore's CEO on KIMMTRAK sales and expanding into PRAME, autoimmune and more

Bahija Jallal talks about the experience Immunocore has gained commercializing KIMMTRAK since its 2022 approval and into what areas she hopes to expand the company's development.





Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page